About: Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.86 (-3.76%)
ADIL NASDAQ Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc share price
Atividade de preço de ADIL
Último preço
$ 4,860
Variação (24h)
-0,19 USD (3,76%)
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
$ 5,05
Último negócio
28 Oct, 11:52 pm GMT+0
Atrasado
28 Oct, 11:52 pm GMT+0
ADIL price performance
Atrasado
28 Oct, 11:52 pm GMT+0
quote.marketSignals